ABT vs. PFE: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ABT and PFE, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | ABT | PFE |
|---|---|---|
| Company Name | Abbott Laboratories | Pfizer Inc. |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Pharmaceuticals |
| Market Capitalization | 229.33 billion USD | 145.01 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ABT and PFE by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ABT | PFE |
|---|---|---|
| 5-Day Price Return | 3.73% | 2.75% |
| 13-Week Price Return | -0.88% | -0.32% |
| 26-Week Price Return | 1.19% | 9.58% |
| 52-Week Price Return | 12.83% | -6.21% |
| Month-to-Date Return | 5.64% | 1.66% |
| Year-to-Date Return | 15.45% | -5.54% |
| 10-Day Avg. Volume | 5.29M | 126.04M |
| 3-Month Avg. Volume | 6.22M | 58.66M |
| 3-Month Volatility | 16.15% | 28.86% |
| Beta | 0.71 | 0.43 |
Profitability
Return on Equity (TTM)
ABT
28.24%
Health Care Equipment & Supplies Industry
- Max
- 29.82%
- Q3
- 15.54%
- Median
- 9.69%
- Q1
- 5.19%
- Min
- -7.98%
In the upper quartile for the Health Care Equipment & Supplies industry, ABT’s Return on Equity of 28.24% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
PFE
10.92%
Pharmaceuticals Industry
- Max
- 38.95%
- Q3
- 20.34%
- Median
- 11.59%
- Q1
- 3.32%
- Min
- -10.91%
PFE’s Return on Equity of 10.92% is on par with the norm for the Pharmaceuticals industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ABT
31.88%
Health Care Equipment & Supplies Industry
- Max
- 24.65%
- Q3
- 14.10%
- Median
- 10.09%
- Q1
- 5.84%
- Min
- -6.13%
ABT’s Net Profit Margin of 31.88% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
PFE
15.65%
Pharmaceuticals Industry
- Max
- 39.07%
- Q3
- 19.28%
- Median
- 13.48%
- Q1
- 5.73%
- Min
- -8.86%
PFE’s Net Profit Margin of 15.65% is aligned with the median group of its peers in the Pharmaceuticals industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ABT
17.51%
Health Care Equipment & Supplies Industry
- Max
- 31.34%
- Q3
- 18.36%
- Median
- 15.07%
- Q1
- 9.62%
- Min
- -0.13%
ABT’s Operating Profit Margin of 17.51% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
PFE
16.52%
Pharmaceuticals Industry
- Max
- 45.58%
- Q3
- 24.35%
- Median
- 18.05%
- Q1
- 7.58%
- Min
- -11.88%
PFE’s Operating Profit Margin of 16.52% is around the midpoint for the Pharmaceuticals industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | ABT | PFE |
|---|---|---|
| Return on Equity (TTM) | 28.24% | 10.92% |
| Return on Assets (TTM) | 16.89% | 4.70% |
| Net Profit Margin (TTM) | 31.88% | 15.65% |
| Operating Profit Margin (TTM) | 17.51% | 16.52% |
| Gross Profit Margin (TTM) | 56.19% | 74.95% |
Financial Strength
Current Ratio (MRQ)
ABT
1.70
Health Care Equipment & Supplies Industry
- Max
- 4.97
- Q3
- 2.92
- Median
- 2.12
- Q1
- 1.54
- Min
- 0.86
ABT’s Current Ratio of 1.70 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
PFE
1.28
Pharmaceuticals Industry
- Max
- 5.45
- Q3
- 2.99
- Median
- 1.98
- Q1
- 1.29
- Min
- 0.78
PFE’s Current Ratio of 1.28 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
ABT
0.25
Health Care Equipment & Supplies Industry
- Max
- 1.62
- Q3
- 0.74
- Median
- 0.47
- Q1
- 0.15
- Min
- 0.00
ABT’s Debt-to-Equity Ratio of 0.25 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
PFE
0.67
Pharmaceuticals Industry
- Max
- 1.79
- Q3
- 0.78
- Median
- 0.31
- Q1
- 0.08
- Min
- 0.00
PFE’s Debt-to-Equity Ratio of 0.67 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
ABT
38.30
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 24.86
- Median
- 9.84
- Q1
- 3.86
- Min
- -21.65
ABT’s Interest Coverage Ratio of 38.30 is in the upper quartile for the Health Care Equipment & Supplies industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
PFE
7.89
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 43.60
- Median
- 10.15
- Q1
- 2.37
- Min
- -42.71
PFE’s Interest Coverage Ratio of 7.89 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | ABT | PFE |
|---|---|---|
| Current Ratio (MRQ) | 1.70 | 1.28 |
| Quick Ratio (MRQ) | 1.09 | 0.97 |
| Debt-to-Equity Ratio (MRQ) | 0.25 | 0.67 |
| Interest Coverage Ratio (TTM) | 38.30 | 7.89 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ABT
1.77%
Health Care Equipment & Supplies Industry
- Max
- 4.36%
- Q3
- 1.87%
- Median
- 0.82%
- Q1
- 0.00%
- Min
- 0.00%
ABT’s Dividend Yield of 1.77% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.
PFE
6.72%
Pharmaceuticals Industry
- Max
- 6.72%
- Q3
- 3.48%
- Median
- 1.90%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 6.72%, PFE offers a more attractive income stream than most of its peers in the Pharmaceuticals industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
ABT
28.93%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 67.77%
- Median
- 28.21%
- Q1
- 0.00%
- Min
- 0.00%
ABT’s Dividend Payout Ratio of 28.93% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
PFE
98.75%
Pharmaceuticals Industry
- Max
- 199.58%
- Q3
- 85.87%
- Median
- 49.36%
- Q1
- 1.12%
- Min
- 0.00%
PFE’s Dividend Payout Ratio of 98.75% is in the upper quartile for the Pharmaceuticals industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
| Symbol | ABT | PFE |
|---|---|---|
| Dividend Yield (TTM) | 1.77% | 6.72% |
| Dividend Payout Ratio (TTM) | 28.93% | 98.75% |
Valuation
Price-to-Earnings Ratio (TTM)
ABT
16.36
Health Care Equipment & Supplies Industry
- Max
- 67.59
- Q3
- 41.41
- Median
- 33.11
- Q1
- 22.82
- Min
- 8.68
In the lower quartile for the Health Care Equipment & Supplies industry, ABT’s P/E Ratio of 16.36 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
PFE
14.69
Pharmaceuticals Industry
- Max
- 52.64
- Q3
- 29.89
- Median
- 20.77
- Q1
- 13.37
- Min
- 5.71
PFE’s P/E Ratio of 14.69 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ABT
5.21
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.92
- Q1
- 1.97
- Min
- 0.61
ABT’s P/S Ratio of 5.21 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
PFE
2.30
Pharmaceuticals Industry
- Max
- 8.74
- Q3
- 4.66
- Median
- 2.37
- Q1
- 1.67
- Min
- 0.11
PFE’s P/S Ratio of 2.30 aligns with the market consensus for the Pharmaceuticals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ABT
4.58
Health Care Equipment & Supplies Industry
- Max
- 10.77
- Q3
- 6.04
- Median
- 3.32
- Q1
- 2.31
- Min
- 0.83
ABT’s P/B Ratio of 4.58 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
PFE
1.46
Pharmaceuticals Industry
- Max
- 9.86
- Q3
- 5.28
- Median
- 2.48
- Q1
- 1.57
- Min
- 0.59
PFE’s P/B Ratio of 1.46 is in the lower quartile for the Pharmaceuticals industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
Valuation at a Glance
| Symbol | ABT | PFE |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 16.36 | 14.69 |
| Price-to-Sales Ratio (TTM) | 5.21 | 2.30 |
| Price-to-Book Ratio (MRQ) | 4.58 | 1.46 |
| Price-to-Free Cash Flow Ratio (TTM) | 33.05 | 12.47 |